Ultralife Corp. (ULBI) Misses Q4 EPS by 3c; Revs Light

Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $31.4 million versus the consensus estimate of $37.6 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
• Carvana (CVNA) PT Lowered to $85 at RBC Capital